Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May 16:11:159.
doi: 10.3389/fnmol.2018.00159. eCollection 2018.

Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs

Claudia A Dumitru  1 , I Erol Sandalcioglu  1 , Meliha Karsak  2
Affiliations
Review

Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs

Claudia A Dumitru et al. Front Mol Neurosci. .

Abstract

Glioblastoma (GBM) is the most malignant brain tumor and one of the deadliest types of solid cancer overall. Despite aggressive therapeutic approaches consisting of maximum safe surgical resection and radio-chemotherapy, more than 95% of GBM patients die within 5 years after diagnosis. Thus, there is still an urgent need to develop novel therapeutic strategies against this disease. Accumulating evidence indicates that cannabinoids have potent anti-tumor functions and might be used successfully in the treatment of GBM. This review article summarizes the latest findings on the molecular effects of cannabinoids on GBM, both in vitro and in (pre-) clinical studies in animal models and patients. The therapeutic effect of cannabinoids is based on reduction of tumor growth via inhibition of tumor proliferation and angiogenesis but also via induction of tumor cell death. Additionally, cannabinoids were shown to inhibit the invasiveness and the stem cell-like properties of GBM tumors. Recent phase II clinical trials indicated positive results regarding the survival of GBM patients upon cannabinoid treatment. Taken together these findings underline the importance of elucidating the full pharmacological effectiveness and the molecular mechanisms of the cannabinoid system in GBM pathophysiology.

Keywords: THC; cannabidiol; cannabinoid receptors; cannabinoids; glioblastoma; molecular mechanisms; novel therapeutic strategies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Summary of the main molecular mechanisms involved in the modulation of glioblastoma (GBM) pathophysiology by cannabinoids.
See this image and copyright information in PMC

References

    1. Adamson C., Kanu O. O., Mehta A. I., Di C., Lin N., Mattox A. K., et al. . (2009). Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin. Investig. Drugs 18, 1061–1083. 10.1517/13543780903052764 - DOI - PubMed
    1. Aguado T., Carracedo A., Julien B., Velasco G., Milman G., Mechoulam R., et al. . (2007). Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis. J. Biol. Chem. 282, 6854–6862. 10.1074/jbc.M608900200 - DOI - PubMed
    1. Blázquez C., Casanova M. L., Planas A., Gómez Del Pulgar T., Villanueva C., Fernández-Aceüero M. J., et al. . (2003). Inhibition of tumor angiogenesis by cannabinoids. FASEB J. 17, 529–531. 10.1096/fj.02-0795fje - DOI - PubMed
    1. Blázquez C., Carracedo A., Salazar M., Lorente M., Egia A., González-Feria L., et al. . (2008a). Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity? Neuropharmacology 54, 235–243. 10.1016/j.neuropharm.2007.06.021 - DOI - PubMed
    1. Blázquez C., Salazar M., Carracedo A., Lorente M., Egia A., González-Feria L., et al. . (2008b). Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression. Cancer Res. 68, 1945–1952. 10.1158/0008-5472.CAN-07-5176 - DOI - PubMed

LinkOut - more resources